List view / Grid view
12 December 2018 | By ACD/Labs
The purpose of process development in pharma is to select and optimise a synthetic route to produce the active pharmaceutical ingredient (API) by the safest, cheapest, fastest, and cleanest (by green chemistry where possible) route, following both Good Laboratory Practice (GLP) and Quality by Design (QbD) principles.
4 December 2018 | By European Pharmaceutical Review
The development of a drug that could be used to save women from postpartum hemorrhaging, could save many thousands of women each year...
27 November 2018 | By European Pharmaceutical Review
NIST researchers have shown how graphene can be modified with pores and used as an ion filter, and could be adapted for use in drug delivery systems...
26 November 2018 | By Eurofins
Companies often need to arrange for the synthesis of test substances to support research and development efforts.
21 November 2018 | By European Pharmaceutical Review
The pharmaceutical industry accounted for 67 percent of the total spending on research and development, with federal government accounting for 22 percent...
21 November 2018 | By BioSpectra
BioSpectra offers US based, custom GMP manufacturing of small molecules...
19 November 2018 | By Gilson
Oligonucleotides must be of high purity when used in molecular biology applications, but efficient purification over a large range of production scales is challenging. The Gilson GX-271 Oligonucleotide Purification System provides a versatile solution for continuous separation, analysis, and desalting of oligonucleotides...
7 November 2018 | By JRS Pharma
JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries...
2 November 2018 | By Ashley Lay (University of Kentucky), Eric J. Munson Professor and Head of the Department of Industrial and Physical Pharmacy at Purdue University, Yongchao Su (Associate Principal Scientist in Pharmaceutical Sciences-Merck)
The emergence of biological drugs has led to an increase in lyophilised drug products in the market. Lyophilisation is a technique used to stabilise parenteral formulations in a solid form with the goal of producing chemically and physically stable, homogeneous, and high-quality lyo-products.
1 November 2018 | By Iqra Farooq (European Pharmaceutical Review)
Medical cannabis is now avaliable through the NHS, but many are warning about its drawbacks and that it won't be available for those who need it...
31 October 2018 | By European Pharmaceutical Review
A report conducted by the University of Strathclyde has revealed that the pharmaceutical market in Scotland is booming with over £462m in exports...
30 October 2018 | By Mostafa Eissa (Hikma Pharmaceuticals)
The microbial population in water is dynamic and may change not only from day to day but also at different times of the day. Researchers have observed that this microbiological distribution usually follows the Poisson or Negative Binomial model.1
30 October 2018 | By Gattefossé
The Gattefossé North America award for excellence in research and development with lipid-based excipients is an annual prize recognising scientific excellence and significant contributions to the field of lipid-based formulations...
24 October 2018 | By G-Con
In this Spotlight on Continuous Manufacturing, G-Con explains how they have simplified the entire design/build/validate process via their prefabricated cleanroom infrastructure line...
22 October 2018 | By European Pharmaceutical Review
In this issue: LC-MS multi-attribute methods for the characterising and QC testing therapeutics, integrating data from Quality Control and Production to enable fast and informed decisions, and Solid-state NMR spectroscopy: using freeze drying to predict the stability of biological products.
Follow: